TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS
Jaime Arango, Chief Financial Officer, Jens Schröder as Chief Medical Officer and Rachel Mooney, Chief Communications Officer BORDEAUX, France, Nov.
Read MoreJaime Arango, Chief Financial Officer, Jens Schröder as Chief Medical Officer and Rachel Mooney, Chief Communications Officer BORDEAUX, France, Nov.
Read MorePHILADELPHIA, Nov. 3, 2023 /PRNewswire/ — Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that
Read MoreSKY-0515 is a small molecule RNA splicing modifier developed through the company’s novel SKYSTAR® platform. SKY-0515’s Phase 1 study will include healthy
Read MoreNATICK, Mass., Oct. 12, 2023 /PRNewswire/ — Allorion Therapeutics (Allorion), a clinical-stage biotechnology company dedicated to the discovery and development of
Read More— STX-721 is characterized by high selectivity and a potentially best-in-class profile — — Scorpion’s second program to enter clinical
Read MoreFinancing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone
Read MoreMUMBAI, India, June 15, 2023 /PRNewswire/ — Wellthy Therapeutics is proud to announce that it has secured additional financing, led by
Read MoreMUMBAI, India and LOS ANGELES, May 11, 2023 /PRNewswire/ — Wellthy Therapeutics, a global leader in digital health and digital
Read MoreUnified technology platform from Medidata to help Lambda Therapeutics leverage centralized data to address the research process from end to
Read MoreMUMBAI, India, March 6, 2023 /PRNewswire/ — Fitterfly, a leading Indian health-tech company, working in the area of diabetes &
Read More